AlzeCure Pharma AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0010133785
SEK
1.86
-1.53 (-45.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Saniona AB
Probi AB
Biovica International AB
Intervacc AB
BioInvent International AB
BICO Group AB
Alligator Bioscience AB
Magle Chemoswed Holding AB
AlzeCure Pharma AB
Mendus AB
Bio-Works Technologies AB

Why is AlzeCure Pharma AB ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is AlzeCure Pharma AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
AlzeCure Pharma AB
-100.0%
-0.06
100.05%
OMX Stockholm 30
17.06%
0.95
17.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
7.32%
EBIT to Interest (avg)
-50.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.30
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
44.41
EV to EBIT
-7.07
EV to EBITDA
-7.11
EV to Capital Employed
-43.12
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-577.74%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET PROFIT(HY)

Higher at SEK -19.44 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-8What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK -35.74 MM

ROCE(HY)

Lowest at -236.55%

OPERATING PROFIT(Q)

Lowest at SEK -10.34 MM

PRE-TAX PROFIT(Q)

Lowest at SEK -10.11 MM

NET PROFIT(Q)

Lowest at SEK -10.11 MM

Here's what is working for AlzeCure Pharma AB

Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for AlzeCure Pharma AB

Operating Cash Flow
Lowest at SEK -35.74 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Operating Profit
Lowest at SEK -10.34 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Pre-Tax Profit
Lowest at SEK -10.11 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (SEK MM)

Net Profit
Lowest at SEK -10.11 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (SEK MM)